LYEL logo

LYEL
Lyell Immunopharma Inc

434
Mkt Cap
$521.85M
Volume
108,598.00
52W High
$45.00
52W Low
$7.65
PE Ratio
-1.48
LYEL Fundamentals
Price
$22.39
Prev Close
$23.85
Open
$24.00
50D MA
$22.66
Beta
1.63
Avg. Volume
99,580.44
EPS (Annual)
-$16.06
P/B
1.92
Rev/Employee
$223.60
$329.90
Loading...
Loading...
News
all
press releases
Lyell Immunopharma, Inc. (NASDAQ:LYEL) Receives Consensus Recommendation of "Hold" from Analysts
Shares of Lyell Immunopharma, Inc. (NASDAQ:LYEL - Get Free Report) have been assigned a consensus recommendation of "Hold" from the five ratings firms that are presently covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a sell rating and three have assigned a b...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Needham & Company LLC Begins Coverage on Lyell Immunopharma (NASDAQ:LYEL)
Needham & Company LLC started coverage on shares of Lyell Immunopharma in a research note on Friday. They issued a "buy" rating and a $44.00 price objective on the stock...
MarketBeat·1d ago
News Placeholder
Lyell Immunopharma (NASDAQ:LYEL) Cut to Strong Sell at Zacks Research
Zacks Research downgraded Lyell Immunopharma from a "hold" rating to a "strong sell" rating in a report on Tuesday...
MarketBeat·3d ago
News Placeholder
Lyell Immunopharma (NASDAQ:LYEL) Trading Up 9.2% - Time to Buy?
Lyell Immunopharma (NASDAQ:LYEL) Trading 9.2% Higher - Time to Buy...
MarketBeat·10d ago
News Placeholder
Lyell Immunopharma (NASDAQ:LYEL) Lowered to Sell Rating by Wall Street Zen
Wall Street Zen cut shares of Lyell Immunopharma from a "hold" rating to a "sell" rating in a report on Saturday...
MarketBeat·15d ago
News Placeholder
Lyell Immunopharma, Inc. $LYEL Shares Acquired by Foresite Capital Management V LLC
Foresite Capital Management V LLC lifted its stake in shares of Lyell Immunopharma, Inc. (NASDAQ:LYEL - Free Report) by 17.3% during the 3rd quarter, according to the company in its most recent 13F...
MarketBeat·27d ago
News Placeholder
Lyell Immunopharma, Inc. (NASDAQ:LYEL) Short Interest Update
Lyell Immunopharma, Inc. (NASDAQ:LYEL - Get Free Report) saw a large increase in short interest in the month of February. As of February 27th, there was short interest totaling 815,248 shares, an...
MarketBeat·28d ago
News Placeholder
Lyell Immunopharma (NASDAQ:LYEL) Releases Earnings Results, Misses Expectations By $5.53 EPS
Lyell Immunopharma (NASDAQ:LYEL - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($7.68) earnings per share (EPS) for the quarter, missing analysts...
MarketBeat·1mo ago
News Placeholder
Lyell Immunopharma (NASDAQ:LYEL) Shares Gap Up - Should You Buy?
Lyell Immunopharma (NASDAQ:LYEL) Shares Gap Up - Still a Buy...
MarketBeat·1mo ago
News Placeholder
Lyell Immunopharma (NASDAQ:LYEL) Now Covered by Citizens Jmp
Citizens Jmp started coverage on shares of Lyell Immunopharma in a research report on Monday. They set a "market outperform" rating and a $34.00 target price on the stock...
MarketBeat·1mo ago
<
1
2
...
>

Latest LYEL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.